

























































New Oleic Acid-Capped Mesoporous Silica Particles as
Surfactant-Responsive Delivery Systems
Elisa Poyatos-Racionero,[a, b] Édgar Pérez-Esteve,[a, c] M. Dolores Marcos,*[a, b, d, f, g]
José M. Barat,[c, e] Ramón Martínez-Máñez,*[a, b, d, f, g] Elena Aznar,[a, b, f, g] and
Andrea Bernardos[a, b, g]
A new delivery microdevice, based on hydrophobic oleic acid-
capped mesoporous silica particles and able to payload release
in the presence of surfactants, has been developed. The oleic
acid functionalization confers to the system a high hydrophobic
character, which avoids cargo release unless surfactant mole-
cules are present. The performance of this oleic-acid capped
microdevice in the presence of different surfactants is presented
and its zero-release operation in the absence of surfactants is
demonstrated.
Controlled delivery has become an essential field of research for
the design of systems able to liberate a cargo upon the
application of specific stimuli, as stimuli-responsive systems
allow to minimize side effects caused by non-controlled
administration.[1] Traditionally, the delivery systems were based
on polymers that released the cargo by diffusion-controlled
processes or through degradation of the polymer container.[2,3]
In the last years, porous hybrid organic-inorganic materials have
merged as a noteworthy and large class of materials.[4–7] These
materials show high surface area, tunable pore size and
versatility in their framework composition, which confer them
an outstanding performance in many fields such as drug
delivery, species adsorption and sensing applications among
others.[8–12] In particular, a promising alternative for controlled
delivery systems are mesoporous silica particles (MSPs) due to
their versatile properties such as low toxicity, high internal
volume and easy chemical functionalization.[13] The opportunity
of functionalizing the external surface of the MSPs with capping
agents and uncap them with predefined stimuli makes these
supports ideal candidates for controlled delivery applications. A
number of examples able to payload deliver in the presence of
physical, chemical and biochemical stimuli have been widely
described.[14–18]
Despite these reported examples, the design of MSPs gated
materials able to control the delivery through the action of
surfactants is still emerging. To the best of our knowledge, only
one example involving surfactant-responsive mesoporous silica
particles has been recently described.[19] In that work, meso-
porous materials loaded with a dye and capped with a lipid
bilayer was prepared. The solid was opened by the rupture of
the lipid bilayer induced by the presence of the surfactant
DTAB (dodecyltrimethylammonium bromide). However, and
despite the appeal of this attractive stimuli-responsible strategy
on MSPs, no more examples of surfactant triggers have been
reported.
Surfactant nature of bile salts from the duodenum has been
thoroughly reported in literature. In addition to play an
important role in cholesterol elimination route, in hormone
secretion or in the stimulation of intestinal immune system, bile
contains surfactant molecules that emulsify ingested fats
facilitating their intestinal absorption.[17,18] However, this charac-
ter of bile salts has not yet been explored as a possible trigger
for capped MSPs to deliver certain molecules in the small
intestine. The small intestine is a relevant place where
controlled release is needed, being the site where the bioactive
molecules absorption takes place.[20] Traditionally, the particles
developed to deliver active molecules in the small intestine use
pH changes and the presence of enzymes as external stimuli,
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despite the inconvenience that these stimulus can be also
present in other parts of the digestive tract.[21,22]
In this scenario, with the aim of exploring the surfactant
properties of bile salts, we present here MSPs capped with
strong hydrophobic lipid molecules (oleic acid) and loaded with
a reporter, rhodamine B (RhB). Our original approach relies on
proving that using lipid-capped silica mesoporous particles a
remarkable delivery control can be obtained as only surfactants
should trigger the release of the cargo, whereas in their
absence, zero release should be maintained.
Lipid molecules have been widely used as carriers of
bioactive molecules, but their use as capping molecules is
scarce in the literature.[23,24] The attachment of lipid molecules
on the MSPs surface originates a hydrophobic layer around the
particles that avoids the release of the loaded cargo. In our
case, oleic acid was selected as capping agent, which confers
the aforementioned hydrophobic character and increases the
bioapplicability of the particles.[25] The presence of oleic acid in
capped-mesoporous silica particles has been described but, as
far as we know, its use as capping system for surfactant-
responsive controlled release has not been reported yet. The
presence of surfactant molecules (as bile salts) was expected to
allow the release of the cargo entrapped into the MSPs, via the
emulsifier action of surfactants on the hydrophobic layer (oleic
acid). The novelty of this work relies on the remarkable effect of
the surfactant nature of bile salts in the controlled release of
the cargo loaded inside the pores of the oleic acid-capped
mesoporous silica particles. As far as we know, this is the first
example of bile salts surfactant-responsive-induced delivery
using lipid-capped silica mesoporous particles.
SBA-15 microparticles were chosen as support in the
envisioned functional MSPs system. SBA-15 was prepared using
Pluronic 123 as micellar template and tetraethylortosilicate
(TEOS) as inorganic precursor. The as-made solid was calcined
at 550 °C for 5 h in order to remove the organic template, and
the resulted porous solid was loaded with RhB (solid S0). Solid
S0 was functionalized firstly with (3-aminopropyl)triethoxysilane
(APTES) to produce the coating of the surface with amino
groups (solid S1) and then with oleic acid by means of
amidation reaction, giving the final solid S2, see Scheme 1. All
the solids were then characterized using standard techniques
(see Supporting information for details).[26] Powder X-ray
diffraction (PXRD), transmission electron microscopy (TEM) and
N2 adsorption-desorption isotherms carried out on the initial
SBA-15 mesoporous particles, clearly showed a mesoporous
structure that remained in solid S2 regardless of the loading
process and further functionalization with APTES and oleic acid.
DLS measurements pointed out an average particle size of 1 μm
for the prepared solids. FTIR spectra was used to follow the
functionalization process through the anchoring of the APTES
moieties in S1 and the formation of the amide bond between
the anchored amines and the oleic acid to form the gating
system in solid S2. Measurements of ζ potential of the different
materials were in agreement with the functionalization process
reaching a value of 44.43 mV in S2, indicative of a stable final
material. Thermogravimetric analysis (TGA) and elemental
analysis (EA) showed an organic matter content of 43.1 mg of
rhodamine B per gram of SiO2 and 84.7 mg of molecular gate
per gram of SiO2 in S2.
Scheme 1. Representation of mesoporous silica material encapsulated with a cargo molecule (RhB) and capped with APTES and the oleic acid layer attached
to the free amine of the APTES. Addition of surfactant (i. e. bile salts) to S2 would uncap the mesopores via emulsifier action.
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In addition to the characterization process applied to all
solids,[26] the release profile of RhB from solid S2 was studied in
the presence and absence of bile salts at 37 °C. In a typical
experiment, 5 mg of S2 were suspended in 10 mL of PBS or in
10 mL of a bile extract solution. At different times an aliquot
was taken, filtered, and the fluorescence signal of RhB measured
(λex=555 nm, λem=572 nm). As depicted in Figure 1 no cargo
release was observed when the solid was suspended in PBS. In
contrast, a remarkable delivery was achieved when bile salts
were present. After 4 hours of the experiment, almost 80% of
the total cargo release was reached.
In order to study the surfactant-responsive controlled-
release protocol in detail, several experiments of RhB release
from S2 in the presence of bile salts, different gastrointestinal
enzymes (pepsin, pancreatin, pronase, and esterase) and differ-
ent surfactants (CTAB, SDS, Triton™ X-100) were carried out.
For this purpose, 5 mg of S2 were suspended in 10 mL of the
corresponding solution, and the suspension was stirred for 10 h
to allow maximum cargo delivery. Figure 2 shows no RhB
release when S2 was suspended in water, PBS or solutions
containing enzymes. However, a high cargo release was
induced when surfactants were present. Comparing the effect
of different surfactants, the release achieved with CTAB, SDS or
Triton™ X-100 was higher than that found with bile salts. It is
tentatively attributed to the fact that the surfactant concen-
tration on bile extract used is between 3 and 8×10  3 M, lower
than the one used for CTAB, SDS or Triton™ X-100. These
experiments demonstrated that only surfactant molecules were
able to open the S2 system, while the solid remains capped
when surfactants are not present.
Having this in mind and taking into account that active
molecules are absorbed in the small intestine,[20] S2 was tested
in an in vitro digestion. The assay was carried out simulating the
digestive steps and conditions of mouth, stomach and small
intestine (see Figure 3). In this experiment, the corresponding
fluids were added after certain times to 5 mg of S2 (3, 6 and
9 mL of simulated saliva, gastric and intestinal fluids, respec-
tively). Aliquots were taken at different times to measure the
fluorescence signal of the RhB release over 5 hours.[26] Figure 3
shows no cargo release from S2 during the mouth and stomach
digestion (saliva and gastric fluid addition), while in the small
intestine, when bile salts were added, the signal of the cargo
increased. This difference is in agreement with the selective
opening of S2 in the presence of the bile salts acting as
surfactant.
Finally, in order to validate the system for biological or
nutritional application, the bioactive molecule riboflavin-5P,
one of the vitamers of vitamin B2, was loaded into the pores of
MSPs. Riboflavin plays important roles in energy metabolism
and is required in the metabolism of amino acids, fatty acids
and carbohydrates. Moreover, it is well established that water-
Figure 1. Kinetic release profile of RhB dye from S2 in a PBS suspension
without bile salts (*) and when bile salts are present (*).
Figure 2. Percentages of dye released from S2 with different stimuli.
Enzymes solutions were prepared in PBS at their optimal pH (7.5 for
pancreatin, pronase and esterase; and 2 for pepsin), in the same
concentration as the one of bile extract (10 mg/mL). Surfactants concen-
tration was 10  2 M.
Figure 3. In vitro digestion of S2, in saliva, gastric fluid and intestinal fluid for
5 hours.
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soluble vitamins, as riboflavin, are absorbed in the intestine via
specific carrier-mediated processes.[27] Interference with absorp-
tion, which occurs in a variety of conditions (e.g. congenital
defects in the digestive or absorptive system, intestinal disease/
resection, drug interaction and chronic alcohol use), leads to
the development of deficiency (and sub-optimal status) and
results in clinical abnormalities.[27] Riboflavin deficit is related
with different diseases as migraine and hypertension,[28]
anemia,[29] brain injury,[30] intestinal disorders[31,32] and also cell
carcinomas.[33] A dietary supplementation with riboflavin could
be an effective therapy for these diseases, or serve as palliative
treatment to decrease the symptoms.[28]
Based on the above-mentioned facts, encapsulation and
controlled release of riboflavin appears to be an important
approach. Then, SBA-15 was loaded with riboflavin-5P, and
afterwards functionalized in two steps with APTES and oleic
acid to obtain the final solid S3 (ζ potential 39.71 mV, 50.0 mg
of Riboflavin-5P per gram of SiO2 and 167.2 mg of molecular
gate per gram of SiO2). Solid S3 release was tested in similar
conditions than solid S2, using water as blank and a surfactant
solution as stimulus, and an analogous behavior was observed.
The riboflavin-5P release in the blank solution was negligible
compared with the one achieved in the presence of
surfactant.[26]
In summary, although several controlled release systems
based on mesoporous silica particles have been described,
none of them uses bile salts or other surfactant as opening
stimulus for gastrointestinal delivery. Lipid systems have been
used as carriers of bioactive molecules, but its performance as
release controllers in the presence of specific stimuli has not
been reported yet. The microdevice presented here has many
advantages such as the high loading capacity typical of
mesoporous silica materials, an expected good biocompatibility
due to the external lipid coating, and specific controlled release
in the presence of surfactants. In conclusion, the synthesis of
new oleic acid-capped mesoporous silica particles as surfactant-
responsive delivery systems for on-command delivery applica-
tions has been described. The zero-release system’s behavior in
the absence of surfactant molecules could make it a useful
protective support for sensitive molecules, and its selective
response to surfactant molecules can be used as specific trigger
for both controlled delivery and sensory applications. In fact,
very good performance of bile salts, similar to that of
commercial surfactants, in the controlled release of the cargo
loaded inside the pores of the oleic acid-capped mesoporous
silica particles was demonstrated. As far as we know, this is the
first example of surfactant-responsive-induced delivery using
lipid-capped silica mesoporous particles. We believe that our
microdevice presented here, possesses high potential for
finding application in the food and pharmaceutical industry.
Experimental Section
Solids Synthesis
In a typical synthesis, 300 mg of SBA-15 were suspended in 20 mL
of an aqueous solution of RhB (115 mg, 0.24 mol) and stirred during
24 h to obtain the loaded solid S0. After that, an excess of APTES
(1.75 mL, 7.48 mmol) was added to the previous mixture, and the
mixture was stirred during 5.5 h. Solid S1 was isolated by
centrifugation and was dried at 37 °C overnight.
Then, 300 mg of S1 were added to a mixture of 50 mg of EDC and
5 mL of oleic acid in 18 mL of ethanol in order to obtain the final
loaded and functionalised solid S2. This solid was washed twice
with an ethanol: water (2 : 1) mixture and dried at 37 °C overnight.
In order to obtain the riboflavin loaded and functionalized solid
(S3), 150 mg of SBA-15 were suspended in a riboflavin solution
[75 mg in 6 mL of a water:methanol (2 : 1) mixture] and stirred
during 24 h. After that, the solid was centrifuged and promptly re-
suspended in 5 mL of acetone. Then an excess of APTES (0.876 mL,
3.74 mmol) was added. The reaction was stirred during 5.5 h,
centrifuged and dried at 37 °C overnight. 50 mg of the dried solid
were added to a mixture of oleic acid (1 mL) and DCC (17 mg) in
acetone (10 mL), and the reaction was stirred overnight. The final
solid S3 was centrifuged, washed twice with ethanol: water (2 : 1)
and dried at 37 °C overnight.
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